secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harpoon Therapeutics, Inc. (—)
CIK:        0001708493
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001193125-23-088198
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Harpoon Therapeutics receives two Nasdaq deficiency notices for bid price and equity
--------------------------------------------------------------------------------

- Bid price below $1.00 for 30 consecutive days; must comply by Sept 25, 2023.
- Stockholders' equity of $5.399M at Dec 31, 2022 fails Nasdaq's $10M minimum.
- Company has 45 days to submit a plan to regain equity compliance or consider transfer to Nasdaq Capital Market.
- For bid price, 180-day cure period with possible extension if other standards met and reverse split considered.
- Company intends to monitor and evaluate options including reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708493/000119312523088198/0001193125-23-088198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708493/000119312523088198/d492534d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-088198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer